- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 11 residues within 4Å:- Chain A: E.178, V.221, L.228, N.229, F.342, N.343, G.345, C.410, V.411, S.412
- Ligands: NAG-NAG.11
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.8: 3 residues within 4Å:- Chain A: T.264, H.296, N.298
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 4 residues within 4Å:- Chain B: V.101, N.115, Y.132, D.287
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.13: 2 residues within 4Å:- Chain B: Q.97, N.119
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 9 residues within 4Å:- Chain C: K.32, E.178, L.228, N.229, F.342, N.343, G.345, V.411, S.412
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.345, C:K.32
- 1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.34: 3 residues within 4Å:- Chain A: N.585, S.587, E.588
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain A: N.604
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain A: N.100, K.114
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain A: N.103, N.104
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain A: N.201, T.203, S.241, H.318
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain A: N.305, S.359, W.361
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain A: K.313, K.317, N.321
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain A: N.352, S.354
- Ligands: NAG-NAG.9, NAG-NAG.10
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: N.578, S.580
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain B: N.585
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: N.100, K.114, R.137
Ligand excluded by PLIPNAG.45: 10 residues within 4Å:- Chain B: V.221, L.228, N.229, N.343, C.410, V.411, S.412
- Ligands: NAG-BMA.16, NAG-NAG.22, NAG.46
Ligand excluded by PLIPNAG.46: 7 residues within 4Å:- Chain B: E.178, G.345, R.409, C.410
- Ligands: NAG-BMA.16, NAG-BMA.16, NAG.45
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain B: N.268, I.289, V.407
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain B: N.321, N.322
Ligand excluded by PLIPNAG.49: 4 residues within 4Å:- Chain B: N.329, S.330, S.331, T.338
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: N.585, E.588
Ligand excluded by PLIPNAG.51: 5 residues within 4Å:- Chain C: K.600, E.601, I.602, S.603, N.604
Ligand excluded by PLIPNAG.52: 1 residues within 4Å:- Chain C: N.55
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: N.100, R.110, G.111
Ligand excluded by PLIPNAG.54: 3 residues within 4Å:- Chain C: Q.142, N.144, K.156
Ligand excluded by PLIPNAG.55: 3 residues within 4Å:- Chain C: K.301, N.305, W.361
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain C: K.317, N.321
Ligand excluded by PLIPNAG.57: 6 residues within 4Å:- Chain C: N.329, S.330, S.331, T.338
- Ligands: NAG-NAG.32, NAG-NAG.32
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain C: S.354, N.358
- Ligands: NAG-NAG.32
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parthasarathy, D. et al., Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies. Nat Commun (2024)
- Release Date
- 2024-08-28
- Peptides
- HIV-1 Envelope glycoprotein BG505 SOSIP: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 27 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 5 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-covalent)
- 25 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parthasarathy, D. et al., Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies. Nat Commun (2024)
- Release Date
- 2024-08-28
- Peptides
- HIV-1 Envelope glycoprotein BG505 SOSIP: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C